1. Home
  2. CNNE vs ANIP Comparison

CNNE vs ANIP Comparison

Compare CNNE & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNNE
  • ANIP
  • Stock Information
  • Founded
  • CNNE 2014
  • ANIP 2001
  • Country
  • CNNE United States
  • ANIP United States
  • Employees
  • CNNE N/A
  • ANIP N/A
  • Industry
  • CNNE Restaurants
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • CNNE Consumer Discretionary
  • ANIP Health Care
  • Exchange
  • CNNE Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • CNNE 1.3B
  • ANIP 1.2B
  • IPO Year
  • CNNE N/A
  • ANIP N/A
  • Fundamental
  • Price
  • CNNE $20.21
  • ANIP $55.67
  • Analyst Decision
  • CNNE Buy
  • ANIP Buy
  • Analyst Count
  • CNNE 2
  • ANIP 7
  • Target Price
  • CNNE $27.00
  • ANIP $77.33
  • AVG Volume (30 Days)
  • CNNE 232.0K
  • ANIP 253.7K
  • Earning Date
  • CNNE 11-12-2024
  • ANIP 11-08-2024
  • Dividend Yield
  • CNNE 2.38%
  • ANIP N/A
  • EPS Growth
  • CNNE N/A
  • ANIP N/A
  • EPS
  • CNNE N/A
  • ANIP N/A
  • Revenue
  • CNNE $461,900,000.00
  • ANIP $555,456,000.00
  • Revenue This Year
  • CNNE N/A
  • ANIP $25.49
  • Revenue Next Year
  • CNNE $0.42
  • ANIP $19.92
  • P/E Ratio
  • CNNE N/A
  • ANIP N/A
  • Revenue Growth
  • CNNE N/A
  • ANIP 23.60
  • 52 Week Low
  • CNNE $16.94
  • ANIP $52.00
  • 52 Week High
  • CNNE $22.99
  • ANIP $70.81
  • Technical
  • Relative Strength Index (RSI)
  • CNNE 39.97
  • ANIP 42.29
  • Support Level
  • CNNE $20.11
  • ANIP $55.29
  • Resistance Level
  • CNNE $20.83
  • ANIP $57.33
  • Average True Range (ATR)
  • CNNE 0.38
  • ANIP 1.88
  • MACD
  • CNNE -0.16
  • ANIP -0.16
  • Stochastic Oscillator
  • CNNE 3.26
  • ANIP 5.34

About CNNE Cannae Holdings Inc.

Cannae Holdings Inc is a holding company that manages and operates a group of companies and investments. The company's reportable segments are Restaurant Group, Dun & Bradstreet, Alight, BKFE, Corporate and Other Affiliate Elimination. Majority of the company's revenue is generated from its Restaurant Group segment which represents the operations of O'Charley's and Ninety Nine Restaurants.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: